Skip to main content
Log in

Association of dopamine receptor D4 (DRD4) gene polymorphism with cardiovascular disease risk factors

  • Published:
Russian Journal of Genetics: Applied Research

Abstract

Dopamine receptor genes are known to be candidate genes, mutations of which may be involved in the development of cardiovascular diseases. The human D4 receptor gene (DRD4) contains a variable number (two to ten copies) of tandem 48-bp repeats in exon 3. The goal of the study was to analyze the association of DRD4 gene polymorphism with cardiovascular disease risk factors in the Russian population: blood pressure (BP), high-density (HDL) and low-density (LDL) lipoprotein cholesterol levels, and the triglyceride level. We genotyped 257 women and 425 men for variable number tandem repeat polymorphism in DRD4. The subjects were Novosibirsk residents of Slavic ethnicity. They were divided either into 7+ (those having the allele of seven or eight repeats) and 7–(two to six repeats) groups or into 2+5+ (two or five repeats) and 2–5–(three, four, six, seven, or eight repeats) groups. We found associations between the 7+ allele and elevated systolic and diastolic BP in women but not in men. Neither sex showed associations between the long variants of the DRD4 gene and pulse blood pressure. The presence of the 2–or 5–allele of the DRD4 polymorphism was associated with low HDL cholesterol levels in women and low total cholesterol levels in men. The polymorphism exerted no significant effects on LDL, HDL, or triglyceride levels in men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ainiyet, B. and Rybakowski, J.K., Suicidal behavior in schizophrenia may be related to low lipid levels, Med. Sci. Monit., 2014, vol. 20, pp. 1486–1490. Bgee. 2014. http://bgeeunilch/bgee/bgee

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Borinskaya, S.A., Kozhekbaeva, Zh.M., Gorbunova, E.V., et al., Analysis of the DRD4 gene polymorphism in populations of Russia and neighboring countries, Russ. J. Genetics, 2004, vol. 40, no. 6, pp. 679–683.

    Article  CAS  Google Scholar 

  • Brunerova, L., Potockova, J., Horacek, J., et al., Central dopaminergic activity influences metabolic parameters in healthy men, Neuroendocrinology, 2013, vol. 97, no. 2, pp. 132–138.

    Article  CAS  PubMed  Google Scholar 

  • Camont, L., Chapman, M.J., and Kontush, A., Biological activities of hdl subpopulations and their relevance to cardiovascular disease, Trends Mol. Med., 2011, vol. 17, no. 10, pp. 594–603.

    Article  CAS  PubMed  Google Scholar 

  • Cipolletta, E., Ciccarelli, M., Izzo, R., et al., A polymorphism within the promoter of the dopamine receptor D1 (DRD1-48A/G) associates with impaired kidney function in white hypertensive patients, Transl. Med. UniSa, 2012, vol. 2, pp. 10–19.

    PubMed Central  PubMed  Google Scholar 

  • Dason, J.S., Smith, A.J., Marin, L., and Charlton, M.P., Cholesterol and f-actin are required for clustering of recycling synaptic vesicle proteins in the presynaptic plasma membrane, J. Physiol., 2014, vol. 592, no. 4, pp. 621–633.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Diffenderfer, M.R. and Schaefer, E.J., The composition and metabolism of large and small LDL, Curr. Opin. Lipidol., 2014, vol. 25, no. 3, pp. 221–226.

    Article  CAS  PubMed  Google Scholar 

  • Elovainio, M., Puttonen, S., Heponiemi, T., et al., Relationship between DRD4 polymorphism and lipid metabolism: what is the role of novelty seeking, Neuropsychobiology, 2005, vol. 51, no. 1, pp. 53–58.

    Article  CAS  PubMed  Google Scholar 

  • Fang, Y.J., Thomas, G.N., Xu, Z.L., et al., An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension, J. Cardiol., 2005, vol. 102, no. 1, pp. 111–116.

    Google Scholar 

  • Gafarov, V.V., Gromova, E.A., Voevoda, M.I., et al., Epidemiological, genetic features of personal anxiety as a risk factor for stroke (WHO “MONICA-psychosocial”), Cerebrovasc. Dis., 2013, vol. 35, suppl. 3, p. 428.

    Google Scholar 

  • Gold, M.S., Blum, K., Oscar-Berman, M., and Braverman, E.R., Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?, Postgrad. Med., 2014, vol. 126, no. 1, pp. 153–177.

    Article  PubMed Central  PubMed  Google Scholar 

  • Grady, D.L., Thanos, P.K., Corrada, M.M., et al., DRD4 genotype predicts longevity in mouse and human, J. Neurosci., 2013, vol. 33, no. 1, pp. 286–291.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Graham, G., Population-based approaches to understanding disparities in cardiovascular disease risk in the united states, Int. J. Gen. Med., 2014, vol. 7, pp. 393–400.

    Article  PubMed Central  PubMed  Google Scholar 

  • Keck, T.M., Suchland, K.L., Jimenez, C.C., et al., Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate, Pharmacol. Biochem. Behav., 2013, vol. 103, no. 4, pp. 831–841.

    Article  CAS  PubMed  Google Scholar 

  • Lamon-Fava, S., Ordovas, J.M., and Schaefer, E.J., Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter, Arterioscler. Thromb. Vasc. Biol., 1999, vol. 19, no. 12, pp. 2960–2965.

    Article  CAS  PubMed  Google Scholar 

  • Louis-Dit-Picard, H., Barc, J., Trujillano, D., et al., KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron, Nat. Genet., 2012, vol. 44, no. 4, pp. 456–460.

    Article  CAS  PubMed  Google Scholar 

  • Luepker, R.V., WHO MONICA project: what have we learned and where to go from here?, Pub. Health Rev., 2012, vol. 33, no. 2, pp. 373–396.

    Google Scholar 

  • Maxwell, A., Are some individuals diagnosed with ADHD prone to alcohol abuse? Consideration of two possible mediating factors for this susceptibility, J. Atten. Disord., 2013, vol. 17, no. 2, pp. 98–101.

    Article  PubMed  Google Scholar 

  • Munafo, M.R., Yalcin, B., Willis-Owen, S.A., and Flint, J., Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data, Biol. Psychiatry, 2008, vol. 63, no. 2, pp. 197–206.

    Article  CAS  PubMed  Google Scholar 

  • Nanko, S., Hattori, M., Ikeda, K., et al., Dopamine D4 receptor polymorphism and schizophrenia, Lancet, 1993, vol. 341, no. 8846, pp. 689–690.

    Article  CAS  PubMed  Google Scholar 

  • Nemoda, Z., Szekely, A., and Sasvari-Szekely, M., Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood, Neurosci. Biobehav. Rev., 2011, vol. 35, no. 8, pp. 1665–1686.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nikolaidis, A. and Gray, J.R., ADHD and the DRD4 exon III 7-repeat polymorphism: an international metaanalysis, Soc. Cogn. Affect. Neurosci., 2010, vol. 5, nos. 2/3, pp. 188–193.

    Article  PubMed Central  PubMed  Google Scholar 

  • O’Meara, N.M., Devery, R.A., Owens, D., et al., Alterations in cellular cholesterol metabolism following administration of 6-hydroxydopamine to rabbits, Br. J. Pharmacol., 1992, vol. 105, no. 2, pp. 495–499.

    Article  PubMed Central  PubMed  Google Scholar 

  • Orth, M. and Bellosta, S., Cholesterol: its regulation and role in central nervous system disorders, Cholesterol, 2012, vol. 2012, p. 292598.

    Article  PubMed Central  PubMed  Google Scholar 

  • Orun, O., Nacar, C., Cabadak, H., et al., Investigation of the association between dopamine D1 receptor gene polymorphisms and essential hypertension in a group of Turkish subjects, Clin. Exp. Hypertens., 2011, vol. 33, no. 6, pp. 418–421.

    Article  CAS  PubMed  Google Scholar 

  • Polymeropoulos, M.H., Licamele, L., Volpi, S., et al., Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia, Schizophr. Res., 2009, vol. 108, nos. 1–3, pp. 134–142.

    Article  PubMed  Google Scholar 

  • Pucadyil, T.J. and Chattopadhyay, A., Role of cholesterol in the function and organization of G-protein coupled receptors, Prog. Lipid Res., 2006, vol. 45, no. 4, pp. 295–333.

    Article  CAS  PubMed  Google Scholar 

  • Ricci, A., Marchal-Victorion, S., Bronzetti, E., et al., Dopamine D4 receptor expression in rat kidney: evidence for preand postjunctional localization, J. Histochem. Cytochem., 2002, vol. 50, no. 8, pp. 1091–1096.

    Article  CAS  PubMed  Google Scholar 

  • Rotella, J.A., Zarei, F., Frauman, A.G., and Greene, S.L., Refractory hypotension treated with vasopressin after intentional clozapine overdose, Eur. J. Emerg. Med., 2014, vol. 21, no. 4, pp. 319–320.

    Article  PubMed  Google Scholar 

  • dos Santos Silva, C.M., Barbosa, F.R., Lima, G.A., et al., BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists, Obesity, 2011, vol. 19, no. 4, pp. 800–805.

    Article  CAS  PubMed  Google Scholar 

  • Sen, S., Nesse, R., Sheng, L., et al., Association between a dopamine-4 receptor polymorphism and blood pressure, Am. J. Hypertens., 2005, vol. 18, no. 9, pp. 1206–1210.

    Article  CAS  PubMed  Google Scholar 

  • Staruschenko, A., Regulation of transport in the connecting tubule and cortical collecting duct, Compar. Physiol., 2012, vol. 2, no. 2, pp. 1541–1584.

    Google Scholar 

  • Tayebati, S.K., Lokhandwala, M.F., and Amenta, F., Dopamine and vascular dynamics control: present status and future perspectives, Curr. Neurovasc. Res., 2011, vol. 8, no. 3, pp. 246–257.

    Article  CAS  PubMed  Google Scholar 

  • Wang, X., Ding, X., Su, S., et al., Genetic influence on blood pressure measured in the office, under laboratory stress and during real life, Hypertens. Res., 2011, vol. 34, no. 2, pp. 239–244.

    PubMed Central  PubMed  Google Scholar 

  • Wu, J., Xiao, H., Sun, H., et al., Role of dopamine receptors in ADHD: a systematic meta-analysis, Mol. Neurobiol., 2012, vol. 45, no. 3, pp. 605–620.

    Article  CAS  PubMed  Google Scholar 

  • Zeng, C., Zhang, M., Asico, L.D., et al., The dopaminergic system in hypertension, Clin. Sci., 2007, vol. 112, no. 12, pp. 583–597.

    Article  CAS  PubMed  Google Scholar 

  • Zeng, C., Armando, I., Luo, Y., et al., Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice, Am. J. Physiol. Heart Circ. Physiol., 2008, vol. 294, no. 2, pp. H551–H569.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. S. Yudin.

Additional information

Original Russian Text © N.S. Yudin, T.M. Mishakova, E.V. Ignatieva, V.N. Maksimov, V.V. Gafarov, S.K. Malyutina, M.I. Voevoda, 2014, published in Vavilovskii Zhurnal Genetiki i Selektsii, 2014, Vol. 18, No. 4/3, pp. 1259–1267.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yudin, N.S., Mishakova, T.M., Ignatieva, E.V. et al. Association of dopamine receptor D4 (DRD4) gene polymorphism with cardiovascular disease risk factors. Russ J Genet Appl Res 5, 650–655 (2015). https://doi.org/10.1134/S2079059715060192

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079059715060192

Keywords

Navigation